Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Non-linear fluvoxamine disposition

O Spigset1, K Granberg, S Hägg

  • 1Division of Clinical Pharmacology, Norrland University Hospital, Umeå, Sweden.

British Journal of Clinical Pharmacology
|March 28, 1998
PubMed
Summary

Fluvoxamine shows non-linear pharmacokinetics in healthy volunteers, with oral clearance decreasing as the dose increases. This suggests complex metabolism rather than simple saturation of a single pathway.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential for carbon dioxide removal by enhanced rock weathering in the tropics: An evaluation of Costa Rica.

The Science of the total environment·2024
Same author

Connections between cross-tissue and intra-tissue biomarkers of aging biology in older adults.

Epigenetics communications·2023
Same author

Neonatal withdrawal syndrome following in utero exposure to antidepressants: a disproportionality analysis of VigiBase, the WHO spontaneous reporting database.

Psychological medicine·2022
Same author

Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19.

Clinical nutrition (Edinburgh, Scotland)·2021
Same author

Technological readiness and implementation of genomic-driven precision medicine for complex diseases.

Journal of internal medicine·2021
Same author

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry·2021

Area of Science:

  • Pharmacology
  • Clinical Pharmacology
  • Drug Metabolism

Background:

  • Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) used to treat depression and anxiety disorders.
  • Understanding the pharmacokinetic profile of fluvoxamine is crucial for optimizing therapeutic efficacy and minimizing adverse effects.

Purpose of the Study:

  • To investigate the pharmacokinetic properties of fluvoxamine in healthy volunteers as doses are progressively increased.
  • To determine if fluvoxamine exhibits linear or non-linear kinetics within the therapeutic dose range.

Main Methods:

  • Ten healthy male non-smokers received escalating doses of fluvoxamine (25-200 mg/day) for four weeks.
  • Serum concentrations of fluvoxamine were monitored weekly, and saliva caffeine/paraxanthine ratios assessed CYP1A2 activity.

Related Experiment Videos

  • Subjects' CYP2D6 metabolic status (extensive vs. poor metabolizers) was determined.

    • Main Results:

    • Area Under the Curve (AUC) for fluvoxamine increased disproportionately with dose escalation, indicating decreased oral clearance (P < 0.0001).
    • Elimination half-life varied depending on the post-discontinuation measurement period, suggesting complex elimination kinetics.
    • No significant correlation was found between CYP1A2 phenotype and fluvoxamine AUCs; CYP2D6 poor metabolizers showed similar AUCs to extensive metabolizers.

    Conclusions:

    • Fluvoxamine demonstrates non-linear pharmacokinetics within the therapeutic dose range.
    • The observed non-linearity is attributed to the complex interplay of multiple metabolic pathways, not Michaelis-Menten saturation of a single pathway.